Recombinant multi-species COQ2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine COQ2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an enzyme that functions in the final steps in the biosynthesis of CoQ (ubiquinone), a redox carrier in the mitochondrial respiratory chain and a lipid-soluble antioxidant. This enzyme, which is part of the coenzyme Q10 pathway, catalyzes the prenylation of parahydroxybenzoate with an all-trans polyprenyl group. Mutations in this gene cause coenzyme Q10 deficiency, a mitochondrial encephalomyopathy, and also COQ2 nephropathy, an inherited form of mitochondriopathy with primary renal involvement. [provided by RefSeq, Oct 2009]
The Alternative Names of target: 2310002F18Rik,4-HB polyprenyltransferase,4-hydroxybenzoate decaprenyltransferase,4-hydroxybenzoate polyprenyltransferase,CL640,COQ10D1,COQ2,COQ2 homolog (hCOQ2),Coq2,MSA1,PHB:PPT,PHB:polyprenyltransferase),Para-hydroxybenzoate--polyprenyltransferase (PHB:PPT,RGD1306722,mitochondrial

Target products collectionGo to COQ2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0592-Ag-1/ GM-Tg-hg-IP0592-Ag-2 Human COQ2 protein Human
GM-Tg-rg-IP0592-Ag-1/ GM-Tg-rg-IP0592-Ag-2 Rat COQ2 protein Rat
GM-Tg-mg-IP0592-Ag-1/ GM-Tg-mg-IP0592-Ag-2 Mouse COQ2 protein Mouse
GM-Tg-cynog-IP0592-Ag-1/ GM-Tg-cynog-IP0592-Ag-2 Cynomolgus/Rhesus macaque COQ2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0592-Ag-1/ GM-Tg-felg-IP0592-Ag-2 Feline COQ2 protein Feline
GM-Tg-cang-IP0592-Ag-1/ GM-Tg-cang-IP0592-Ag-2 Canine COQ2 protein Canine
GM-Tg-bovg-IP0592-Ag-1/ GM-Tg-bovg-IP0592-Ag-2 Bovine COQ2 protein Bovine
GM-Tg-equg-IP0592-Ag-1/ GM-Tg-equg-IP0592-Ag-2 Equine COQ2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0592-Ag-1/ GM-Tg-hg-IP0592-Ag-2; GM-Tg-rg-IP0592-Ag-1/ GM-Tg-rg-IP0592-Ag-2;
GM-Tg-mg-IP0592-Ag-1/ GM-Tg-mg-IP0592-Ag-2; GM-Tg-cynog-IP0592-Ag-1/ GM-Tg-cynog-IP0592-Ag-2;
GM-Tg-felg-IP0592-Ag-1/ GM-Tg-felg-IP0592-Ag-2; GM-Tg-cang-IP0592-Ag-1/ GM-Tg-cang-IP0592-Ag-2;
GM-Tg-bovg-IP0592-Ag-1/ GM-Tg-bovg-IP0592-Ag-2; GM-Tg-equg-IP0592-Ag-1/ GM-Tg-equg-IP0592-Ag-2
Products Name COQ2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name COQ2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine COQ2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.